Solamargine Inhibits Prostate Cancer Cell Growth and Enhances the Therapeutic Efficacy of Docetaxel via Akt Signaling

Prostate cancer (PCa) has become a leading cause of cancer-associated incidence and mortality in men worldwide. However, most primary PCas relapse to castration-resistant PCa (CRPC) after androgen deprivation treatment. The current treatment for CRPC is based on chemotherapeutic drugs such as doceta...

Descripción completa

Detalles Bibliográficos
Autores principales: Ge, Jianchao, Wang, Pengyu, Ma, Hangbin, Zhang, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8930254/
https://www.ncbi.nlm.nih.gov/pubmed/35310915
http://dx.doi.org/10.1155/2022/9055954

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8930254/
https://www.ncbi.nlm.nih.gov/pubmed/35310915
http://dx.doi.org/10.1155/2022/9055954

Ejemplares similares